Arrhythmias & electrophysiology

Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy

Circ Arrhythm ElectrophysiolPublished Multicentre observational phenotype-genotype study

Authors' conclusion

The anatomic substrate of SMVTs shows a strong correlation with the underlying genotype, electrocardiographic morphology, and recurrence rate. Particularly, patients with nuclear membrane gene variants have a significantly higher recurrence rate compared with those with desmosomal gene variants.

Study context

Population
Patients with inherited high-risk genetic cardiomyopathy with LV involvement and sustained monomorphic ventricular tachycardia (SMVT) treated by electrophysiological study76% men
Participants
71 patients
Exposure
Genotype groups
Outcome
Location and electrophysiological profile of SMVT substrate by genotype
Methodological details18 European/US centres
  • 18 European/US centres

Main finding

As reported in the abstract

Clinical-SMVT substrate location by genotype

Substrate location differed significantly by genotype

P=0.005

Desmosomal genes, TMEM43, PLN biventricular disease; LMNA and cytoskeleton predominant LV involvement

P=0.001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Recurrence of clinical SMVT after ablation · median 26 Q1-Q3 (10.6-65) monthsNuclear membrane vs Desmosomal4.56 (1.5–13.8)
Recurrence of clinical SMVT after ablation — Recurrence in all patients
27%
Recurrence of clinical SMVT after ablation — Differences between genotypes (log-rank)
0.016

Original publication

Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol. Published 29 November 2024. doi:10.1161/circep.124.013145

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.